275 related articles for article (PubMed ID: 30625249)
1. Noninvasive screening by cell-free DNA for 22q11.2 deletion: Benefits, limitations, and challenges.
Grati FR; Gross SJ
Prenat Diagn; 2019 Jan; 39(2):70-80. PubMed ID: 30625249
[TBL] [Abstract][Full Text] [Related]
2. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
3. Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome.
Dar P; Jacobsson B; Clifton R; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Strong N; Haeri S; Silver R; Vohra N; Hyett J; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Daly S; Hallingström M; MacPherson C; Kao C; Hakonarson H; Norton ME
Am J Obstet Gynecol; 2022 Jul; 227(1):79.e1-79.e11. PubMed ID: 35033576
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.
Hu H; Wang L; Wu J; Zhou P; Fu J; Sun J; Cai W; Liu H; Yang Y
Hum Genomics; 2019 Mar; 13(1):14. PubMed ID: 30871627
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes.
Shaffer BL; Norton ME
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):13-26. PubMed ID: 29428281
[TBL] [Abstract][Full Text] [Related]
6. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
Gray KJ; Wilkins-Haug LE
Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
[TBL] [Abstract][Full Text] [Related]
7. Screening for 22q11.2 deletion syndrome by two non-invasive prenatal testing methodologies: A case with discordant results.
Lo LM; Shiau CS; Chen KC; Shaw SWS; Benn P
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):40-42. PubMed ID: 30638477
[TBL] [Abstract][Full Text] [Related]
8. Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort.
Bevilacqua E; Jani JC; Chaoui R; Suk EA; Palma-Dias R; Ko TM; Warsof S; Stokowski R; Jones KJ; Grati FR; Schmid M
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):597-602. PubMed ID: 34090308
[TBL] [Abstract][Full Text] [Related]
9. The benefits and limitations of cell-free DNA screening for 22q11.2 deletion syndrome.
Dugoff L; Mennuti MT; McDonald-McGinn DM
Prenat Diagn; 2017 Jan; 37(1):53-60. PubMed ID: 27329064
[TBL] [Abstract][Full Text] [Related]
10. Prenatal Screening and Diagnostic Considerations for 22q11.2 Microdeletions.
Blagowidow N; Nowakowska B; Schindewolf E; Grati FR; Putotto C; Breckpot J; Swillen A; Crowley TB; Loo JCY; Lairson LA; Óskarsdóttir S; Boot E; Garcia-Minaur S; Cristina Digilio M; Marino B; Coleman B; Moldenhauer JS; Bassett AS; McDonald-McGinn DM
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672900
[TBL] [Abstract][Full Text] [Related]
11. Maternal cell-free DNA-based screening for fetal microdeletion and the importance of careful diagnostic follow-up.
Yatsenko SA; Peters DG; Saller DN; Chu T; Clemens M; Rajkovic A
Genet Med; 2015 Oct; 17(10):836-8. PubMed ID: 25569438
[TBL] [Abstract][Full Text] [Related]
12. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
Langlois S; Duncan A; ;
J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
[TBL] [Abstract][Full Text] [Related]
13. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.
Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM
J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086
[TBL] [Abstract][Full Text] [Related]
14. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
15. Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory.
Guy C; Haji-Sheikhi F; Rowland CM; Anderson B; Owen R; Lacbawan FL; Alagia DP
Mol Genet Genomic Med; 2019 Mar; 7(3):e545. PubMed ID: 30706702
[TBL] [Abstract][Full Text] [Related]
16. Update in non-invasive prenatal testing.
D'ambrosio V; Squarcella A; Vena F; Di Mascio D; Corno S; Pajno C; Piccioni MG; Brunelli R; Pizzuti A; Benedetti Panici P; Giancotti A
Minerva Ginecol; 2019 Feb; 71(1):44-53. PubMed ID: 30318870
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome.
Gross SJ; Stosic M; McDonald-McGinn DM; Bassett AS; Norvez A; Dhamankar R; Kobara K; Kirkizlar E; Zimmermann B; Wayham N; Babiarz JE; Ryan A; Jinnett KN; Demko Z; Benn P
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):177-83. PubMed ID: 26396068
[TBL] [Abstract][Full Text] [Related]
18. Confined placental mosaicism for 22q11.2 deletion as the etiology for discordant positive NIPT results.
Bunnell M; Zhang C; Lee C; Bianchi DW; Wilkins-Haug L
Prenat Diagn; 2017 Apr; 37(4):416-419. PubMed ID: 28198030
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive prenatal testing.
Harraway J
Aust Fam Physician; 2017 Oct; 46(10):735-739. PubMed ID: 29036772
[TBL] [Abstract][Full Text] [Related]
20. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
